- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- monomer
- Ligands
- 1 x CIT: CITRIC ACID(Non-functional Binders)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x RXZ: SPHINX31(Non-covalent)
RXZ.24: 21 residues within 4Å:- Chain A: L.31, W.33, G.34, S.37, V.39, A.52, K.54, F.110, E.111, V.112, L.113, G.114, H.115, L.165, V.168, Y.172, I.173, L.176, A.224, D.225
- Ligands: EDO.16
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:L.31, A:V.39, A:A.52, A:F.110, A:F.110, A:L.113
- Hydrogen bonds: A:L.113
- pi-Stacking: A:H.115
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Batson, J. et al., Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease. ACS Chem. Biol. (2017)
- Release Date
- 2017-05-10
- Peptides
- SRSF protein kinase 1,SRSF protein kinase 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- monomer
- Ligands
- 1 x CIT: CITRIC ACID(Non-functional Binders)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x RXZ: SPHINX31(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Batson, J. et al., Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease. ACS Chem. Biol. (2017)
- Release Date
- 2017-05-10
- Peptides
- SRSF protein kinase 1,SRSF protein kinase 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A